Results 291 to 298 of about 441,361 (298)
Some of the next articles are maybe not open access.
Circulation
AIM The "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy" provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy.
S. Ommen +21 more
semanticscholar +1 more source
AIM The "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy" provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy.
S. Ommen +21 more
semanticscholar +1 more source
Transthyretin Amyloid Cardiomyopathy
European Heart JournalTransthyretin amyloidosis (ATTR-CM) is an infiltrative cardiomyopathy caused by the deposition of amyloid fibrils, leading to heart failure, arrhythmias, and increased mortality. ATTR-CM prevalence is rising.
Paschalis Karakasis
semanticscholar +1 more source
Clinical Course and Management of Hypertrophic Cardiomyopathy
New England Journal of Medicine, 2018Hypertrophic Cardiomyopathy HCM is the most common genetic disorder of the heart, with 1 case per 200 to 500 persons, and often remains clinically silent.
B. Maron
semanticscholar +1 more source
Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy
Nature, 2022M. Chaffin +18 more
semanticscholar +1 more source
Pathophysiology of sepsis-induced cardiomyopathy
Nature Reviews Cardiology, 2021S. Hollenberg, M. Singer
semanticscholar +1 more source
Hypertrophic cardiomyopathy: a systematic review.
Journal of the American Medical Association (JAMA), 2002B. Maron
semanticscholar +1 more source
Molecular mechanism of doxorubicin‐induced cardiomyopathy – An update
European Journal of Pharmacology, 2018Kaviyarasi Renu +3 more
semanticscholar +1 more source